Advance | $8,550,000 | (Feb 6, 2026)
Turnstile | $29,000,000 | (Feb 6, 2026)
Accrual | $75,000,000 | (Feb 6, 2026)
Evrima Technologies
Australia
- Sydney, NSW
- 05/09/2022
- Unknown
- $3,000,000
Our vision is to be an innovative organisation that truly engages and enriches society through clinical trial awareness and participation. We are striving to make a global impact on overall clinical trial timelines and enable the industry to advance medical research swiftly.
Our mission is to automate the study start-up and patient recruitment processes using predictive technology to reduce inaccuracies, repetitive administrative headaches that study teams, sponsors and patients experience. Ultimately we want to have a direct impact on the overall time it takes for new and improved medicines to become available to those who need them.
- Industry Hospital & Health Care
- Website https://evrima.com.au/
- LinkedIn https://www.linkedin.com/company/evrimatechnologies/
Related People
Charlotte BradshawFounder
Australia -
ND
Experienced patient recruitment specialist with strong project management and digital marketing expertise across various therapeutic areas and trial phases. Client-focused and driven to achieve innovative solutions.
Connect Music | $80,000,000 | (Feb 6, 2026)
adaption | $50,000,000 | (Feb 6, 2026)
Cadastral | $9,500,000 | (Feb 6, 2026)
Nixtla | $16,000,000 | (Feb 6, 2026)
Nullify | $12,500,000 | (Feb 6, 2026)
Uplift360 | $8,724,008 | (Feb 6, 2026)
Fundamental | $255,000,000 | (Feb 6, 2026)
Duna | $35,365,500 | (Feb 6, 2026)
Flock AI | $6,000,000 | (Feb 6, 2026)